LA MARCA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.059
AS - Asia 13.550
EU - Europa 10.734
SA - Sud America 2.172
Continente sconosciuto - Info sul continente non disponibili 472
AF - Africa 353
OC - Oceania 85
Totale 64.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.120
SG - Singapore 4.369
GB - Regno Unito 2.850
CN - Cina 2.833
IT - Italia 2.387
HK - Hong Kong 1.969
BR - Brasile 1.662
VN - Vietnam 1.536
SE - Svezia 1.130
DE - Germania 890
FI - Finlandia 790
BD - Bangladesh 776
UA - Ucraina 599
RU - Federazione Russa 541
CA - Canada 481
TR - Turchia 428
FR - Francia 412
IN - India 306
KR - Corea 257
BG - Bulgaria 244
NL - Olanda 183
ID - Indonesia 182
AR - Argentina 180
JP - Giappone 151
MX - Messico 142
ES - Italia 137
IQ - Iraq 112
ZA - Sudafrica 90
EC - Ecuador 78
PL - Polonia 76
CO - Colombia 73
PK - Pakistan 71
AU - Australia 65
RO - Romania 64
PH - Filippine 62
CR - Costa Rica 61
AE - Emirati Arabi Uniti 60
IR - Iran 52
CL - Cile 51
MY - Malesia 51
IE - Irlanda 50
VE - Venezuela 50
UZ - Uzbekistan 45
MA - Marocco 43
DZ - Algeria 42
BE - Belgio 39
LT - Lituania 39
DK - Danimarca 38
JM - Giamaica 38
CH - Svizzera 37
HN - Honduras 37
IL - Israele 35
KE - Kenya 35
AT - Austria 34
CZ - Repubblica Ceca 34
SC - Seychelles 34
EG - Egitto 31
TW - Taiwan 31
PY - Paraguay 29
SA - Arabia Saudita 28
TH - Thailandia 28
NI - Nicaragua 26
SV - El Salvador 25
JO - Giordania 24
NP - Nepal 24
GT - Guatemala 23
TN - Tunisia 22
AL - Albania 20
TT - Trinidad e Tobago 19
PR - Porto Rico 18
BO - Bolivia 17
DO - Repubblica Dominicana 17
KZ - Kazakistan 17
NZ - Nuova Zelanda 17
PE - Perù 17
AZ - Azerbaigian 16
HR - Croazia 15
NG - Nigeria 15
GP - Guadalupe 14
NO - Norvegia 14
HU - Ungheria 12
LV - Lettonia 12
MD - Moldavia 12
PS - Palestinian Territory 12
CW - ???statistics.table.value.countryCode.CW??? 11
GR - Grecia 11
PT - Portogallo 11
UY - Uruguay 11
EE - Estonia 10
PA - Panama 9
ET - Etiopia 8
OM - Oman 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
BA - Bosnia-Erzegovina 7
EU - Europa 7
GH - Ghana 7
QA - Qatar 7
AM - Armenia 6
BB - Barbados 6
Totale 63.841
Salva come PNG Salva come JPEG
Città #
Ashburn 4.811
Fairfield 3.903
Singapore 2.723
Santa Clara 2.526
Hong Kong 1.918
Woodbridge 1.887
Southend 1.737
Houston 1.602
Seattle 1.499
Cambridge 1.309
San Jose 1.274
Wilmington 1.179
Chandler 1.126
Jacksonville 911
Council Bluffs 851
Ann Arbor 759
Dearborn 681
Helsinki 679
Nyköping 675
Beijing 639
London 634
Hefei 590
Los Angeles 528
Ho Chi Minh City 494
New York 414
Chicago 405
Modena 400
The Dalles 380
Hanoi 340
San Diego 305
Milan 264
Boardman 249
Princeton 248
Dallas 246
Sofia 235
Seoul 212
Izmir 207
Lauterbourg 194
Eugene 193
Buffalo 187
Moscow 185
São Paulo 177
Columbus 170
Rome 161
Shanghai 139
Atlanta 125
Phoenix 121
Bremen 119
Salt Lake City 114
Jakarta 112
Tokyo 106
Toronto 98
Bologna 87
Munich 87
Guangzhou 86
North Bergen 84
Frankfurt am Main 83
San Francisco 82
Orem 79
Montreal 78
Denver 77
Da Nang 74
Tampa 74
Brooklyn 69
Naples 68
Redwood City 68
Amsterdam 67
Redondo Beach 65
Haiphong 64
Vancouver 60
Saint Augustine 58
Warsaw 54
Philadelphia 51
Rio de Janeiro 50
Washington 48
Chennai 47
San José 47
Elk Grove Village 45
Baghdad 44
Dublin 43
Johannesburg 43
Mexico City 42
Norfolk 42
Stockholm 42
Winnipeg 42
Falls Church 40
Norwalk 40
Boston 39
Tashkent 39
Biên Hòa 38
Fremont 37
Miano 37
Turin 37
Honolulu 35
Newark 35
Charlotte 34
Kilburn 34
Melbourne 34
Nanjing 34
Florence 32
Totale 43.636
Salva come PNG Salva come JPEG
Nome #
The complex relationship between female age and embryo euploidy 1.115
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial 676
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 598
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 574
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome 561
Anti-Mullerian hormone (AMH): what do we still need to know? 507
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study 476
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice 475
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 466
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach 462
MATER protein as substrate of PKCepsilon in human cumulus cells. 434
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 423
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 389
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria 388
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles 387
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 385
From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology 381
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 377
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos 373
Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder 367
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 365
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 365
The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH 362
FSHR polymorphism p.N680S mediates different responses to FSH in vitro 362
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium 361
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 358
How Much Does AMH Really Vary in Normal Women? 354
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 350
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol 347
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 343
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 343
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 340
Elevated levels of nitrous dioxide are associated with lower AMH levels: A real-world analysis 340
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 337
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 333
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles 333
Primary ovarian insufficiency: autoimmune causes. 331
Vitamin D and ovarian reserve: making clinical decisions 331
Periodontal disease and nitric oxide levels in low risk women with preterm labor 327
The physiology and clinical utility of anti-Mullerian hormone in women 325
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 325
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study 324
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 323
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 323
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome 323
The management of vaginal agenesis: report of 104 cases 320
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study 315
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation 314
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro 310
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 307
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro 307
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 307
Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women 307
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 307
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 306
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 305
Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea 305
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) 304
The use of ovarian reserve markers in IVF clinical practice: a national consensus 299
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 299
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 299
Adrenal adenocarcinoma and empty sella syndrome in a 37-year-old woman 297
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 297
Metformin treatment of PCOS during adolescence and the reproductive period 296
Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids 295
Gonadotrophins modulate cell death-related genes expression in human endometrium 295
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients 292
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 290
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 288
Utero-vaginal anastomosis in the treatment of cervical atresia 287
The ovarian follicular pool and reproductive outcome in women. 286
Rectus abdominis muscle endometriosis: Case report and review of the literature 286
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology 286
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome 283
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis 283
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study 282
Serum anti-Mullerian hormone throughout the human menstrual cycle 281
Reply: The two sides of the individualization of controlled ovarian stimulation 280
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 276
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 276
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes 275
How to personalize ovarian stimulation in clinical practice 272
8th World Congress of Gynecological Endocrinology 271
Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy 267
Rectovaginal fistula repair using fascia graft of autologous abdominal muscles 267
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 265
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 265
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age 264
The journey from the old to the new AMH assay: how to avoid getting lost in the values 263
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia 263
Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply 262
Anti-Müllerian hormone: clairvoyance or crystal clear? 262
Soluble L-selectin levels during controlled ovarian hyperstimulation 262
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 262
How adenomyosis changes throughout pregnancy: A retrospective cohort study 262
Gonadotropins in the Management of Couple Infertility: Toward the Rational Use of an Empirical Therapy 261
Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone 260
T-shaped uterus: What has been done, what should be done 260
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome 258
A benefit-risk assessment of medical treatment for uterine leiomyomas 258
Totale 33.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 251.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 251.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.855 0 0 0 0 84 175 345 216 415 356 872 392
2022/20233.625 454 416 349 293 473 434 82 308 414 39 174 189
2023/20243.007 95 153 122 270 479 180 510 456 68 95 131 448
2024/20258.209 260 89 107 581 1.510 1.099 434 449 1.158 519 786 1.217
2025/202618.625 1.057 530 1.581 2.000 2.208 1.427 2.410 1.109 1.884 1.583 1.490 1.346
2026/20278.428 1.546 1.606 1.714 2.794 768 0 0 0 0 0 0 0
Totale 64.425